Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Antiplatelet Drugs in COVID-19: Mechanism of Action and Effect on Prognosis — Jack Bell (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Antiplatelet Drugs in COVID-19: Mechanism of Action and Effect on Prognosis
Shared by
Professor Gregory Lip
University of Liverpool
Antiplatelet Drugs in COVID-19: Mechanism of Action and Effect on Prognosis
Chapter In A Book
2022
en
Related publications
Article
2020
Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis
Stefano Figliozzi
,
Pier Giorgio Masci
,
Navid Ahmadi
,
Lara Tondi
,
Evangelia Koutli
,
Alberto Aimo
,
Κimon Stamatelopoulos
,
Meletios A Dimopoulos
,
Alida L.P. Caforio
,
Georgios Georgiopoulos
Letter
2020
ACE Inhibitors and Angiotensin II Receptor Blockers May Have Different Impact on Prognosis of COVID-19
Authors
JB
Jack Bell
Professor Gregory Lip
University of Liverpool
RP
Riccardo Proietti
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Yueying Wang
,
Gary Tse
,
Guangping Li
,
Professor Gregory Lip
,
Tong Liu
Letter
2021
Assess COVID-19 prognosis … but be aware of your instrument’s accuracy!
Maurizia Capuzzo
,
André Carlos Kajdacsy-Balla Amaral
,
Jean Louis Vincent
Preprint
2021
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions
William HK Schilling
,
James J. Callery
,
Arjun Chandna
,
Raph L Hamers
,
James A Watson
,
Sir Nicholas White
Wellcome Open Research
Preprint
2021
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions
William HK Schilling
,
James J. Callery
,
Arjun Chandna
,
Raph L Hamers
,
James A Watson
,
Sir Nicholas White
Wellcome Open Research
Discussion(0)
No comments yet. Be the first to comment.